FDA Adverse Event Injury Summary report: N

ORTHOVISC

MDR report key: 2926173 · Received January 16, 2013

Report

Report Number
3007093114-2013-00001
Event Type
Injury
Date Received
January 16, 2013
Date of Event
November 23, 2012
Report Date
January 16, 2013
Manufacturer
ANIKA THERAPEUTICS INC.
Product Code
MOZ
PMA / PMN Number
P030019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT AVAILABLE TO BE RETURNED AND THE LOT NUMBER IS UNK. NO FURTHER EVALUATION OR INVESTIGATION IS POSSIBLE.

Description of Event or Problem · 1

ON (B)(6) 2012 - 1ST BILATERAL ORTHOVISC INJECTION - NO ADVERSE REACTION. ON (B)(6) 2012 - 2ND BILATERAL ORTHOVISC INJECTION - PA INJECTED THE LEFT KNEE, THE PT MOVED DUE TO PAIN AND THE NEEDLE CAME OUT OF THE KNEE WHICH CAUSED THE LIQUID TO DRIPPED TO THE FLOOR. THE PA RE-INJECTED THE REMAINING PRODUCT INTO THE SAME KNEE. PT SUFFERED FROM SEVERE SWELLING, BRUISING AND HEART PALPITATIONS POST INJECTION. ON (B)(6) 2012 - THE PT WAS HOSPITALIZED, RECEIVED AN OPERATION FOR STRANGULATION OF THE BOWELS AND SUFFERED A HEART ATTACK/STROKE. ON (B)(6) 2012 - THE PT RETURNED TO HER ATTENDING PHYSICIAN WHO CONFIRMED HIS CLAIM REGARDING TO PRODUCT BEING INJECTED INTO AN ARTERY OR VEIN. PT DID NOT RECEIVE THE 3RD INJECTION OF ORTHOVISC DUE TO SWELLING IN THE KNEE AND WAS PRESCRIBED METHYL PREDNISONE. TO DATE, THE PT IS RECEIVING REHABILITATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
24487 ORTHOVISC SODIUM HYALURONATE FOR INTRA-ARTICULAR MOZ ANIKA THERAPEUTICS INC. 630-254

Patients

Seq Age Sex Outcome Treatment
1 84 YR Hospitalization| R